OPUS GENETICS, INC.
Last · NasdaqCM$4.64-0.01 (-0.22%)stale · yahoo · 63h ago
Vol 1.62M ≈ 7.52M
MA10MA20MA50
Market cap$386.03M83.2M sh
P/E · TTM-3.7fwd -6.5 · eps -1.27 · loss
Beta0.62vs S&P 500
Div yield0.00%annual · TTM
52w range
$1.70$7.07
Volume1.6Msession
Issuer
Legal nameOPUS GENETICS, INC.
HQUnited States (US)
ListingUS IRD
ISINUS67577R1023
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001228627
CIK0001228627
Websiteopusgtx.com
Employees28
AddressOcuphire Pharma, Inc. 8 Davis Drive 27709, Durham
Loading chart…
Upcoming earnings
WED.11NOV
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.15
Est. revenue
2.1M
Earnings transcripts
Press & signals
- GlobeNewswire
Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- GlobeNewswire
Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update
Documents
FormReporting forFiledFlags
Showing 5 of 19 filings